Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125695031 | 12569503 | 1 | I | 20160707 | 20160719 | 20160719 | EXP | DE-BFARM-16229844 | DE-ACTAVIS-2016-15747 | WATSON | 0.00 | M | Y | 77.00000 | KG | 20160719 | CN | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125695031 | 12569503 | 1 | SS | Atorvastatin (Unknown) | ATORVASTATIN | 1 | Oral | 20 MG, DAILY | Y | UNCONFIRMED | 0 | 20 | MG | UNK | QD | ||||
| 125695031 | 12569503 | 2 | PS | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 20 MG, DAILY | Y | UNCONFIRMED | 76939 | 20 | MG | UNK | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125695031 | 12569503 | 1 | Hypercholesterolaemia |
| 125695031 | 12569503 | 2 | Hypercholesterolaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125695031 | 12569503 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125695031 | 12569503 | Blood creatine phosphokinase increased | |
| 125695031 | 12569503 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125695031 | 12569503 | 1 | 201511 | 201605 | 0 | |
| 125695031 | 12569503 | 2 | 2007 | 2013 | 0 |